Comments on: AstraZeneca reveals 12% rise in first half product sales https://ukinvestormagazine.co.uk/astrazeneca-reveals-12-rise-in-first-half-product-sales/ UK Investor Magazine provides breaking financial news and investment ideas Fri, 20 Dec 2019 10:05:16 +0000 hourly 1 https://wordpress.org/?v=6.9.4 By: AstraZeneca sell two cancer drug rights for $198 million causing shares to spike - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-reveals-12-rise-in-first-half-product-sales/#comment-13337 Fri, 20 Dec 2019 10:05:16 +0000 https://ukinvestormagazine.co.uk/?p=21101#comment-13337 […] to both drugs in the United States were already sold in 2017. Juvise paid $181 million upfront to AstraZeneca, and may make additional sales dependent payments up to a total of $17 […]

]]> By: AstraZeneca shares dip despite Chinese marketing approval - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-reveals-12-rise-in-first-half-product-sales/#comment-13046 Thu, 05 Dec 2019 16:20:08 +0000 https://ukinvestormagazine.co.uk/?p=21101#comment-13046 […] have had a stellar 2019, as the firm firstly reported a 12% rise in first half year sales back in July, which saw shares in […]

]]> By: Integumen stung by losses despite 540% revenue hike - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-reveals-12-rise-in-first-half-product-sales/#comment-11636 Wed, 11 Sep 2019 12:54:18 +0000 https://ukinvestormagazine.co.uk/?p=21101#comment-11636 […] MGP), EMIS Group (LON: EMIS), OptiBiotix Health PLC (LON: OPTI) NMC Health (LON: NMC), Astrazeneca plc (LON: AZN) […]

]]>